Showing 7,381 - 7,400 results of 20,793 for search '"Therapy"', query time: 0.10s Refine Results
  1. 7381

    IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis by Robin Rauniyar, Aman Mishra, Sanjeev Kharel, Subarna Giri, Rohit Rauniyar, Shikha Yadav, Gajendra Chaudhary

    Published 2022-01-01
    “…This study supports the use of IVIG with glucocorticoids compared to IVIG alone, as the combination therapy significantly lowered the risk of treatment failure and the need for adjunctive immunomodulatory therapy.…”
    Get full text
    Article
  2. 7382
  3. 7383

    Long Course Hyperbaric Oxygen Stimulates Neurogenesis and Attenuates Inflammation after Ischemic Stroke by Ying-Sheng Lee, Chung-Ching Chio, Ching-Ping Chang, Liang-Chao Wang, Po-Min Chiang, Kuo-Chi Niu, Kuen-Jer Tsai

    Published 2013-01-01
    “…Mobilization of BMSCs to an ischemic area was more improved in long course HBO treatments, suggesting the duration of therapy is crucial for promoting the homing of BMSCs to ischemic brain by HBO therapies. …”
    Get full text
    Article
  4. 7384
  5. 7385

    Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome by Andrea Berkes, Edit Szikszay, János Kappelmayer, Adrienne Kerényi, Tamás Szabó, László Ujhelyi, Krisztina Bari, György Balla, József Balla

    Published 2017-01-01
    “…As previous attempts of immune modulation therapy were unsuccessful, renal replacement therapy was supplemented by the cytokine absorber CytoSorb. …”
    Get full text
    Article
  6. 7386

    High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea by WonGun Kwack, YunJeong Lim, ChiYeon Lim, David Y. Graham

    Published 2016-01-01
    “…The eradication rate of Helicobacter pylori (H. pylori) following standard triple therapy has declined over the past few decades. This study has determined whether high dose dual therapy (PPI and amoxicillin) is adequate for eradicating H. pylori in Korea. …”
    Get full text
    Article
  7. 7387
  8. 7388

    Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis by A. O. Golovenko, I. L. Khalif, O. V. Golovenko, V. V. Veselov

    Published 2013-10-01
    “…Aim of investigation. Biological therapy by monoclonal antibodies against tumor necrosis factor (infliximab) allows to avoid colectomy at steroid-resistant severe attack of ulcerative colitis. …”
    Get full text
    Article
  9. 7389

    Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021 by Kyoung Hwa Ha, Soyoung Shin, EunJi Na, Dae Jung Kim

    Published 2025-02-01
    “…However, the proportion of individuals receiving monotherapy or dual combination therapy decreased by 9.2 percentage points, whereas the proportion prescribed triple or more combination therapy increased. …”
    Get full text
    Article
  10. 7390

    Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells by Eliane Aparecida Rosseto-Welter, Leticia D’argenio-Garcia, Filipa Blasco Tavares Pereira Lopes, Ana Eduarda Zulim Carvalho, Fernando Flaquer, Vanessa Severo-Lemos, Claudia Concer Viero Nora, Flavio Steinwurz, Lucas Pires Garcia Oliveria, Thiago Aloia, Luiz Vicente Rizzo, Cristóvão Luis Pitangueira Mangueira, Karina Inacio Carvalho

    Published 2022-01-01
    “…There are two main treatments for Chron’s disease: biological therapy and nonbiological therapy. Biological agent therapy (e.g., anti-TNF) is the most frequently prescribed treatment; however, it is not universally accessible. …”
    Get full text
    Article
  11. 7391

    Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis by Huan Chen, Jiaming Lei, Sicheng Liang, Gang Luo, Mingming Deng, Muhan Lü

    Published 2021-01-01
    “…We performed a meta-analysis to evaluate the safety and efficacy of anticoagulant therapy and prophylactic anticoagulant therapy in cirrhosis patients with (/without) portal vein thrombosis. …”
    Get full text
    Article
  12. 7392

    The Diagnosis and Treatment of Infantile Nystagmus Syndrome (INS) by Sangeeta Khanna, Louis F. Dell'Osso

    Published 2006-01-01
    “…Determination of the direct effects of peripheral and central INS therapies can only be made by pre- and post-therapy comparisons of the nystagmus characteristics, specifically of the quality of the foveation periods within each cycle. …”
    Get full text
    Article
  13. 7393

    Rectal Application of Ozone to Patients with Diabetes Mellitus by Omar Morejón Barroso, Imandra María García Menéndez, Leticia Varela Castro, Ernesto Julio Bernal Valladares

    Published 2023-02-01
    “…<br /><strong>Conclusions:</strong> rectal ozone therapy can be used as a complementary therapy to the conventional treatment of patients with diabetes mellitus, since it improves glycemia parameters.…”
    Get full text
    Article
  14. 7394

    The Role of Clopidogrel in 2020: A Reappraisal by Giuseppe Patti, Giuseppe Micieli, Claudio Cimminiello, Leonardo Bolognese

    Published 2020-01-01
    “…This review discusses the available evidence concerning antiplatelet therapy in patients with CVD, with a focus on the role of clopidogrel. …”
    Get full text
    Article
  15. 7395

    Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis by K. S. Zemlyanukhina, I. N. Tikhonov, M. S. Zharkova, O. Yu. Kiseleva, R. Т. Rzayev, V. T. Ivashkin

    Published 2024-10-01
    “…The patient received effective antiviral therapy with drugs using an interferon-free regimen. …”
    Get full text
    Article
  16. 7396

    Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors by Zixi Wu, Junbiao Zhang, Le Li, Zhihua Wang, Chunguang Yang

    Published 2025-12-01
    “…In cases where traditional first-line treatments prove ineffective, the potential of immune checkpoint blockade (ICB) therapy emerges as a promising approach for managing mCRPC. …”
    Get full text
    Article
  17. 7397
  18. 7398

    A rare neurosurgical emergency: case report of spontaneous lumbar subdural empyema by Svetozar Stanković, Milan Lepić, Ivan Bogićević, Jadranka Stanković, Goran Pavlicević

    Published 2025-02-01
    “…Initial broad-spectrum antibiotic therapy was followed by targeted therapy (vancomycin and levofloxacin) for three weeks, and then oral cephalosporins for four weeks. …”
    Get full text
    Article
  19. 7399

    Tumour Debulking for Esophageal Cancer - Thermal Modalities by David Fleischer

    Published 1992-01-01
    “…Esophageal cancer usually is discovered at a late stage and curative therapy seldom is possible. The prognosis is poor and most therapy is palliative. …”
    Get full text
    Article
  20. 7400